CV SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0525 USD | +2.94% |
|
+5.00% | +48.31% |
| 14/05 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to the CV Sciences...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
Sector
Pharmaceuticals
Calendar
03/06/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +48.31% | 85.69L | |
| +38.51% | 73TCr | |
| +33.05% | 60TCr | |
| -6.23% | 35TCr | |
| +18.78% | 33TCr | |
| +1.35% | 28TCr | |
| +16.00% | 24TCr | |
| +8.09% | 20TCr | |
| -5.77% | 20TCr | |
| +6.19% | 16TCr |
- Stock Market
- Equities
- CVSI Stock
- News CV Sciences, Inc.
- Transcript : CV Sciences, Inc., Q2 2020 Earnings Call, Aug 06, 2020
